Claudius Llc - Net Worth and Insider Trading

Claudius Llc Net Worth

The estimated net worth of Claudius Llc is at least $178 Million dollars as of 2024-04-26. Claudius Llc is the 10% Owner of MedAssets Inc and owns about 5,674,635 shares of MedAssets Inc (MDAS) stock worth over $178 Million. Claudius Llc is also the of Acura Pharmaceuticals Inc and owns about 0 shares of Acura Pharmaceuticals Inc (ACUR) stock worth over $0. Details can be seen in Claudius Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Claudius Llc has not made any transactions after 2017-12-14 and currently still holds the listed stock(s).

Transaction Summary of Claudius Llc

To

Claudius Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Claudius Llc owns 2 companies in total, including Acura Pharmaceuticals Inc (ACUR) , and MedAssets Inc (MDAS) .

Click here to see the complete history of Claudius Llc’s form 4 insider trades.

Insider Ownership Summary of Claudius Llc

Ticker Comapny Transaction Date Type of Owner
ACUR Acura Pharmaceuticals Inc 2017-12-14 10 percent owner
MDAS MedAssets Inc 2010-05-18 10 percent owner

Claudius Llc Latest Holdings Summary

Claudius Llc currently owns a total of 2 stocks. Among these stocks, Claudius Llc owns 5,674,635 shares of MedAssets Inc (MDAS) as of May 18, 2010, with a value of $178 Million and a weighting of 100%. Claudius Llc also owns 0 shares of Acura Pharmaceuticals Inc (ACUR) as of December 14, 2017, with a value of $0 and a weighting of 0%.

Latest Holdings of Claudius Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDAS MedAssets Inc 2010-05-18 5,674,635 31.35 177,899,807
ACUR Acura Pharmaceuticals Inc 2017-12-14 0 0.01 0

Holding Weightings of Claudius Llc


Claudius Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Claudius Llc has made a total of 0 transactions in MedAssets Inc (MDAS) over the past 5 years. The most-recent trade in MedAssets Inc is the sale of 30,856 shares on May 18, 2010, which brought Claudius Llc around $743,938.

According to the SEC Form 4 filings, Claudius Llc has made a total of 0 transactions in Acura Pharmaceuticals Inc (ACUR) over the past 5 years. The most-recent trade in Acura Pharmaceuticals Inc is the sale of 2,195,734 shares on December 14, 2017, which brought Claudius Llc around $219,573.

Insider Trading History of Claudius Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Claudius Llc Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Claudius Llc Ownership Network

Ownership Network List of Claudius Llc

No Data

Ownership Network Relation of Claudius Llc


Claudius Llc Owned Company Details

What does Acura Pharmaceuticals Inc do?

Who are the key executives at Acura Pharmaceuticals Inc?

Claudius Llc is the 10 percent owner of Acura Pharmaceuticals Inc. Other key executives at Acura Pharmaceuticals Inc include VP & Corporate Development James F Emigh , VP & Treasurer & Controller Robert A Seiser , and President & CEO Robert B Jones .

Acura Pharmaceuticals Inc (ACUR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Acura Pharmaceuticals Inc (ACUR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acura Pharmaceuticals Inc (ACUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Acura Pharmaceuticals Inc (ACUR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acura Pharmaceuticals Inc Insider Transactions

No Available Data

Claudius Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Claudius Llc. You might contact Claudius Llc via mailing address: C/o Galen Associates 610 Fifth Avenue 5th Floor New York Ny 10020.

Discussions on Claudius Llc

No discussions yet.